General Catalyst Leads $90M Series E For Maven Clinic

Maven Clinic, a New York-based provider of a virtual clinic in women’s and family health, raised $90m in Series E funding.

The round was led by General Catalyst, with participation from CVS Health Ventures, La Famiglia, Intermountain Ventures, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. This brings Maven’s total funding to $300m.

The company intends to use the funds to continue to invest in personalization across its platform to drive meaningful outcomes in both commercial and Medicaid populations, enhance localization of resources to meet the cultural and country-specific needs of its global members, and increase depth of support across all family and reproductive health life stages.

Founded in 2014 by CEO Kate Ryder, Maven is a virtual clinic for women’s and family health, offering continuous, holistic care for fertility and family building through maternity, parenting, pediatrics and menopause. Its digital programs are used by employers and health plans to reduce costs and drive better maternal health outcomes, as well as enhance DE&I in benefits programs.

The technology platform offers 24/7 virtual care, easy financial reimbursement, peer communities, and concierge support to members across 175 countries.

Maven has also appointed three executives with expertise building healthcare companies as independent board members: Jennifer Schneider, M.D., M.S., co-founder and CEO of Homeward and former President of Livongo Health; Yvette Bright, former Chief Operating Officer of Independence Blue Cross; and Chris Klomp, technology entrepreneur and former CEO and Chairman of Collective Medical.